The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy
- PMID: 28351574
- DOI: 10.1016/j.oraloncology.2017.02.009
The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy
Abstract
Objectives: To evaluate the impact of time to treatment initiation (TTI) on overall survival in patients with head-and-neck squamous cell carcinoma (HNSCC).
Materials and methods: In the period 2003-2009, 1616 HNSCC patients were diagnosed in Friuli Venezia Giulia Region, Northeastern Italy, including 462 oral, 346 oropharyngeal, 212 hypopharyngeal, and 596 laryngeal cancers. Clinical information, including date and type of first treatment, and follow-up were retrieved from the regional Cancer Registry and a population-based health database collecting comprehensive health information on people living in the Region. Multivariate hazard ratio (HR) and confidence intervals (CI) were calculated through Cox model.
Results: Overall, the median TTI was 28days, (Q1-Q3: 13-45days), but significant variations emerged according to anatomical site, cancer stage, treatment approach, and care transition to specialized centers. Five-year overall survival decreased with increasing treatment delay from 62% for TTI<30days to 39% for TTI≥90days (p<0.01). HR of death was 1.13 (95% CI: 0.92-1.39) for TTI between 45-89days, and 1.47 (1.05-2.05) for TTI≥90days. The association between TTI and poor prognosis was stronger for laryngeal cancers and early-stage HNSCCs. Further, care transition from community hospitals to specialized centers was associated to a better prognosis (HR=0.73; 95% CI: 0.60-0.88).
Conclusion: Our study findings suggest that HNSCC patients treated within 45days from diagnosis have increased survival probabilities and that early-stage patients suffered the most from treatment delay. Furthermore, care transition to specialized centers -though competitive to timely treatment- improves survival by providing the most innovative technologies and treatment approaches.
Keywords: Head and neck cancer; Survival; Treatment delay.
Copyright © 2017. Published by Elsevier Ltd.
Comment in
-
On the studies of time periods in head and neck cancer diagnosis and treatment.Oral Oncol. 2018 Feb;77:137. doi: 10.1016/j.oraloncology.2017.12.015. Epub 2017 Dec 27. Oral Oncol. 2018. PMID: 29289443 No abstract available.
Similar articles
-
Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy.Med Oncol. 2019 Feb 28;36(4):31. doi: 10.1007/s12032-019-1256-2. Med Oncol. 2019. PMID: 30815763
-
Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database.Cancer. 2015 Apr 15;121(8):1204-13. doi: 10.1002/cncr.29191. Epub 2014 Dec 9. Cancer. 2015. PMID: 25490875
-
Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.Cancer. 2018 Apr 1;124(7):1400-1414. doi: 10.1002/cncr.31213. Epub 2018 Jan 9. Cancer. 2018. PMID: 29315499
-
The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center.Oral Oncol. 2014 Apr;50(4):282-90. doi: 10.1016/j.oraloncology.2013.12.018. Epub 2014 Jan 7. Oral Oncol. 2014. PMID: 24405882
-
Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.Int J Pediatr Otorhinolaryngol. 2017 Jan;92:75-81. doi: 10.1016/j.ijporl.2016.11.005. Epub 2016 Nov 12. Int J Pediatr Otorhinolaryngol. 2017. PMID: 28012539 Review.
Cited by
-
The duration of intervals on the oral cancer care pathway and implications for survival: a systematic review and meta-analysis.Front Public Health. 2023 Aug 8;11:1183244. doi: 10.3389/fpubh.2023.1183244. eCollection 2023. Front Public Health. 2023. PMID: 37614446 Free PMC article. Review.
-
Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic.Head Neck. 2021 Nov;43(11):3493-3497. doi: 10.1002/hed.26858. Epub 2021 Sep 8. Head Neck. 2021. PMID: 34494330 Free PMC article.
-
Mono-institutional retrospective cohort analysis of the insurance status dependent access to ENT-professionals and survival in head and neck squamous cell carcinoma.BMC Health Serv Res. 2021 Jan 8;21(1):45. doi: 10.1186/s12913-020-06035-2. BMC Health Serv Res. 2021. PMID: 33419421 Free PMC article.
-
Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening program.Head Neck. 2021 Feb;43(2):473-484. doi: 10.1002/hed.26504. Epub 2020 Oct 13. Head Neck. 2021. PMID: 33047420 Free PMC article.
-
Association of Care Processes With Timely, Equitable Postoperative Radiotherapy in Patients With Surgically Treated Head and Neck Squamous Cell Carcinoma.JAMA Otolaryngol Head Neck Surg. 2018 Dec 1;144(12):1105-1114. doi: 10.1001/jamaoto.2018.2225. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 30347012 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical